Search
Menu

FDA Approves Laser Phototherapy Device for Hair Restoration in Men

Facebook X LinkedIn Email
Medical device maker Theradome has received U.S. FDA clearance to market its LH80 PRO laser phototherapy hair restoration device to men.

Theradome's LH80 PRO Laser Helmet, which uses laser phototherapy to stimulate hair growth, is now U.S. FDA-approved for use by men. Courtesy of Theradome.
Theradome's LH80 PRO Laser Helmet, which uses laser phototherapy to stimulate hair growth, is now U.S. FDA-approved for use by men. Courtesy of Theradome.

Previously only available to women, the LH80 PRO Laser Helmet uses laser phototherapy to stimulate weak hair follicles and provide them with targeted laser energy. The laser energy improves the cellular metabolism and protein synthesis required to grow and maintain a healthy head of hair.

Therapy protocol with the LH80 PRO is two 20-minute treatments each week. It uses 80 red lasers to generate over 440 J of energy and treat the full scalp area. The lasers deliver the optimum wavelength of light for hair growth — 678 nm.

Theradome is a medical therapy company located in Silicon Valley focused on developing advanced laser phototherapy devices and complementary scalp products.

Published: April 2018
Glossary
phototherapy
Phototherapy is a medical treatment that involves the use of light to treat various conditions, particularly those related to the skin or mood disorders. There are different types of phototherapies, each tailored to address specific conditions: UV phototherapy: This form of phototherapy utilizes ultraviolet (UV) light to treat skin conditions such as psoriasis, eczema, vitiligo, and certain types of dermatitis. UV radiation can suppress the immune system and reduce inflammation, leading to...
BusinessBiophotonicshair resorationFDALasersphototherapyTheradomeRapidScan

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.